Elevated serum/plasma NfL and GFAP levels have been consistently found across patients hospitalized with COVID-19, in a severity-dependent manner [21], particularly associated with an unfavorable short-term outcome [3,22,23,24]. The gene discussed is NEFL; the disease is COVID-19.